EUVIMEDEUVIMED entdecken
Crossref

2,5-Dimethoxy-4-methylamphetamine (DOM)-induced gait alterations in mice: Dissecting the role of 5-HT2A/2C receptor-mediated mechanisms

Bin Li, Shanshan Jiang, Yishan Yao, Gang Yu, Ruibin Su

European Journal of Pharmacology · 2025

DOI: 10.1016/j.ejphar.2025.178170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Bin Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of National Security Specially Needed Medicines, Beijing, China. Hauptthemen laut MEDLINE: DOM 2,5-Dimethoxy-4-Methylamphetamine, Gait, Receptor, Serotonin, 5-HT2A, Receptor, Serotonin, 5-HT2C. Die Arbeit nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychedelics have demonstrated significant therapeutic potential in treating various psychiatric disorders; however, their effects on motor function remain poorly understood. This study investigated the impact of 2,5-dimethoxy-4-methylamphetamine (DOM), a classical phenethylamine psychedelic agent, on gait parameters in C57BL/6J mice using an active gait monitoring system. We found that 0.3-3 mg/kg DOM significantly increased locomotor velocity by enhancing stride frequency and length while reducing stance duration. These effects were accompanied by decreased plantar pressure and more concentrated paw placement patterns. High-dose DOM (10 mg/kg) suppressed voluntary locomotion, which was reversible by 5-HT2C receptor antagonism. Pharmacological studies using subtype-selective serotonin receptor antagonists revealed that DOM's effects on gait parameters were primarily mediated through 5-HT2A receptors. Pretreatment with 0.1 mg/kg MDL100907, but not 1 mg/kg SB242084, normalized DOM-induced gait alterations. Moreover, the antagonism of 5-HT2A or 5-HT2C receptor alone modified baseline gait parameters, suggesting the complex serotonergic regulation of locomotor function. These findings reveal alterations in fine gait parameters following DOM administration, expanding our understanding of the complicated effects of psychedelics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DOM 2,5-Dimethoxy-4-MethylamphetamineGaitReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CSerotonin 5-HT2 Receptor AgonistsMaleAnimalsMiceMice, Inbred C57BLSerotonin 5-HT2 Receptor AntagonistsLocomotionHallucinogens

Stichwörter der Autor:innen

5-HT(2A) receptorDOMGait analysisPsychedelics

Substanzen

DOM 2,5-Dimethoxy-4-MethylamphetamineReceptor, Serotonin, 5-HT2AReceptor, Serotonin, 5-HT2CSerotonin 5-HT2 Receptor AntagonistsHallucinogensSerotonin 5-HT2 Receptor Agonists

Autor:innen und Institutionen

  • State Key Laboratory of National Security Specially Needed Medicines, Beijing, China.
  • State Key Laboratory of National Security Specially Needed Medicines, Beijing, China. Electronic address: yg1st@163.com.
  • State Key Laboratory of National Security Specially Needed Medicines, Beijing, China. Electronic address: ruibinsu@126.com.

Zitieren

APA

Li, B., Jiang, S., Yao, Y., Yu, G., & Su, R. (2025). 2,5-Dimethoxy-4-methylamphetamine (DOM)-induced gait alterations in mice: Dissecting the role of 5-HT2A/2C receptor-mediated mechanisms. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178170

Vancouver

Li B, Jiang S, Yao Y, Yu G, Su R. 2,5-Dimethoxy-4-methylamphetamine (DOM)-induced gait alterations in mice: Dissecting the role of 5-HT2A/2C receptor-mediated mechanisms. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178170

BibTeX
@article{Li2025,
  author = {Li, Bin and Jiang, Shanshan and Yao, Yishan and Yu, Gang and Su, Ruibin},
  title = {2,5-Dimethoxy-4-methylamphetamine (DOM)-induced gait alterations in mice: Dissecting the role of 5-HT2A/2C receptor-mediated mechanisms},
  journal = {European Journal of Pharmacology},
  year = {2025},
  doi = {10.1016/j.ejphar.2025.178170}
}
Kostenlos starten →